Literature DB >> 2669225

Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.

R M Oliver1, A J Peacock, J S Fleming, D G Waller.   

Abstract

The effects of 28 days' treatment with captopril or with placebo on renal and pulmonary function were evaluated in nine patients with stable pulmonary heart disease. Captopril (25 mg twice daily) caused a 17% rise in effective renal plasma flow but no change in glomerular filtration rate, resulting in a fall in filtration fraction likely to favour natriuresis. Captopril did not alter FEV1, lung volumes, or arterial oxygen or carbon dioxide tension.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2669225      PMCID： PMC1020814          DOI： 10.1136/thx.44.6.513

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  9 in total

1.  The renal circulation in chronic pulmonary disease and pulmonary heart failure.

Authors:  J D HAMMOND; J MACKINNON; W D SMITH; C H STUART-HARRIS
Journal:  Q J Med       Date:  1956-07

2.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.

Authors:  D F DAVIES; N W SHOCK
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

3.  Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

Authors:  G Düsterdieck; G McElwee
Journal:  Eur J Clin Invest       Date:  1971-11       Impact factor: 4.686

4.  Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.

Authors:  S A Atlas; D B Case; J E Sealey; J H Laragh; D N McKinstry
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

5.  Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques.

Authors:  D G Waller; C M Keast; J S Fleming; D M Ackery
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

6.  Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.

Authors:  S Kubo; A Nishioka; H Nishimura; K Kawamura; T Takatsu
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

7.  The effects of angiotensin-converting enzyme inhibition on sodium handling in patients with advanced chronic obstructive pulmonary disease.

Authors:  M O Farber; M H Weinberger; G L Robertson; N S Fineberg
Journal:  Am Rev Respir Dis       Date:  1987-10

8.  Abnormalities of sodium and H2O handling in chronic obstructive lung disease.

Authors:  M O Farber; L R Roberts; M H Weinberger; G L Robertson; N S Fineberg; F Manfredi
Journal:  Arch Intern Med       Date:  1982-07

9.  New formulas for the calculation of effective renal plasma flow.

Authors:  W N Tauxe; E V Dubovsky; T Kidd; F Diaz; L R Smith
Journal:  Eur J Nucl Med       Date:  1982
  9 in total
  7 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Pulmonary hypertension due to chronic hypoxia.

Authors:  A Peacock
Journal:  BMJ       Date:  1990-03-24

3.  Renal functional reserve in patients with severe chronic obstructive pulmonary disease.

Authors:  R A Sharkey; E M Mulloy; I A Kilgallen; S J O'Neill
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

4.  Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.

Authors:  R J MacFadyen; K R Lees; J D Gemmill; W S Hillis; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

5.  Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P Baylis; P Howard
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

6.  Short term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease.

Authors:  S V Baudouin; J Bott; A Ward; C Deane; J Moxham
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

7.  Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale.

Authors:  A G Stewart; P A Bardsley; S V Baudouin; J C Waterhouse; J S Thompson; A H Morice; P Howard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.